Divya Mohan

机构：Amgen (United States)

发表论文 4 篇 · 总被引 161 次 · h-index 3

代表论文

• Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD (2023 · European Respiratory Review · 被引 127)
• Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial* (2022 · Critical Care Medicine · 被引 24)
• Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review (2025 · Respiratory Research · 被引 9)
• Late Breaking Abstract - Randomised, placebo-controlled trial of astegolimab for COPD with frequent exacerbations: ALIENTO (2025 · 被引 1)